STUDY OF FIXED DOSE COMBINATIONS IN A TERTIARY CARE HOSPITAL

Shaunak A Pisal; Sujata A Jadhav; Chitra C Khanwelkar; Vandana M Thorat; Somnath M Matule

doi:10.22159/ajpcr.2016.v9s3.12615

Authors

Shaunak A Pisal
Sujata A Jadhav Krishna Institute of Medical Sciences Deemed University.
Chitra C Khanwelkar
Vandana M Thorat
Somnath M Matule

DOI:

https://doi.org/10.22159/ajpcr.2016.v9s3.12615

Abstract

ABSTRACT
Objective: To study and analyze the pattern of fixed dose combinations (FDCs) in medicine outpatient clinic.
Methods: The study is prospective cross-sectional study was conducted for 2 months in medicine outpatient clinic in tertiary care hospital. After
taking approval from Institutional Ethics Committee, the data were collected on every working day of the hospital. Prescriptions from the patients
coming to medicine outpatient clinic outpatient department were taken and required information is filled in data record form.
Results: A total of 83 prescriptions were included in the study. Out of 287 drugs, 111, i.e., 39.92% were fixed dose formulations. As per drug category
analysis, nutritional supplements were used (47.74%). While 27.02% and 9.03% of FDCs were given for cardiovascular complains and respiratory
complains, respectively. FDCs used for other conditions were 16.21%. About 29.72% of total FDCs are included in approved list of FDCs by Drugs
Controller General of India (DCGI), November 2014.
Conclusion: 39.92% drugs are FDCs out of total prescribed drugs. Nutritional supplements are prescribed in higher concentrations. Out of total FDCs
only 29.72% were included in DCGI approved list of FDCs and only four FDCs are found in the WHO list of essential drugs.
Keywords: Fixed dose combinations, Prescriptions, Approved, Drugs Controller General of India.

Downloads

Download data is not yet available.

Author Biography

Sujata A Jadhav, Krishna Institute of Medical Sciences Deemed University.

Professor, Department of Pharmacology, Krishna Institute of Medical Sciences, Karad, Maharashtra, India.

References

Fixed Dose Combinations - World Health Organisation; Apps.Who.Int. FDC Document (WHO TRS 929 Annex5). Available from: http://www.apps.who.int/prequal/info_applicants/Guidelines/info_for_applicants_guidelines_fdcs.htm.

Sreedhar D, Subramanian G, Udupa N. Combination drugs: Are they rational? Curr Sci 2006;91:406.

World Health Organization. The Use of Essential Drugs. WHO Technical Report Series 825. Geneva: World Health Organization; 1992.

Tripathi KD. Essentials of Medical Pharmacology. 7th ed. New Delhi: Jaypee Brothers; 1988. p. 61-2.

Poudel A, Palaian S, Shankar PR, Jayasekera J, Izham MI. Irrational fixed dose combinations in Nepal: Need for intervention. Kathmandu Univ Med J (KUMJ) 2008;6:399-405.

Rayasa SP, Hire RC, Deshmukh PS, Gaikwad NN. The irrational fixed dose combinations in the Indian drug market; An evaluation of prescribing pattern using WHO guidelines. Int J Basic Clin Pharmacol 2013;2(4):452-7.

Amitava S. Indian marketâ€™s fixation with fixed dose combinations. Ration Drug Bull 2002;12:1.

Balat JD, Gandhi AM, Patel PP, Dikshit RK. A study of use of fixed dose combinations in Ahmedabad, India. Indian J Pharmacol 2014;46(5):503-9.

Bangalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-dose combinations improve medication compliance: A meta-analysis. Am J Med 2007;120(8):713-9.